Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 8/25/2025

Increased Filtration in Unaffected Glomeruli and Progressive Kidney Function Loss

Pathophysiology of Glomerular Hyperfiltration in CKD

  • Surviving glomeruli develop increased single-nephron filtration rates to maintain overall kidney function, a phenomenon known as glomerular hyperfiltration, which occurs through efferent arteriolar vasoconstriction coupled with afferent arteriolar dilation, increasing intraglomerular pressure 1, 3
  • The local renin-angiotensin system is activated, causing preferential constriction of the efferent arteriole over the afferent arteriole, further raising intraglomerular pressure 3
  • These hemodynamic changes initially help maintain global GFR despite fewer functioning nephrons 3

Mechanism of Progressive Kidney Injury

  • Sustained increased intraglomerular pressure damages the glomerular filtration barrier 1, 3
  • The increased hemodynamic stress on surviving glomeruli accelerates glomerulosclerosis 2

Clinical Relevance in Diabetic Kidney Disease

  • Long-standing type 2 diabetes has caused initial nephron loss 3
  • The biopsy showing segmental sclerosis indicates ongoing glomerular damage 1
  • Rising creatinine and increasing albuminuria reflect the consequences of hyperfiltration 3
  • Despite good blood pressure control, kidney function continues to decline due to this maladaptive hyperfiltration 2

Therapeutic Implications

  • ACE inhibitors and ARBs reduce intraglomerular pressure by preferentially dilating the efferent arteriole, reducing hyperfiltration, as recommended by the American Heart Association 4

Distinguishing from Other Options

  • Decreased plasma creatinine would indicate improving kidney function, not progression, according to the National Kidney Foundation 5
  • Decreased urine protein would suggest improvement in glomerular barrier function 3
  • Increased formation of new bone mineral is not directly related to kidney disease progression, as stated by the American Society of Nephrology 6